Clinical Trial Update: Chloroquine for Reducing Immune Activation in HIV- Infected Individuals [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated chloroquine for reducing immune activation in HIV-infected individuals. The study has completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Chloroquine (chloroquine)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2014-09-05